Is Medication Information for Children with Autism Spectrum Disorder Monitored and Coordinated Across Professionals? Findings from a Teacher Survey
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Prescription medications are commonly used for children with autism spectrum disorder (ASD); however, there is little research regarding how the effect of medication is monitored across settings once prescribed. The present study addressed this issue for children with ASD in school by administering a questionnaire to teachers of students with ASD who were and were not being given medication. Specifically, the questionnaire assessed the teachers’ knowledge about whether the child was being given medication, and whether behavior changes or side effects were being communicated in any way to the child’s family and prescribing physician. The results showed that for children who were being given medication, fewer than half of the teachers reported knowing the child was being given medication. For those children who were not being given medication, only 53 % of the teachers reported correct information for their students. Of the teachers who knew their students were being given medication, all reported that they were not conferring with the child’s prescribing physician regarding behavioral observations or side effects. Whether teachers are blind to the medication types and dosage the students are being given or not, some type of communication to physicians about the children’s behavior at school is important. Given the importance of monitoring medication for children with ASD, implications for system change, for professionals and for funding agencies, are discussed.
- Aman, M. G., Lam, K. S. L., & Van Bourgondien, M. E. (2005). Medication patterns in patients with autism: Temporal, regional, and demographic influences. Journal of Child and Adolescent Psychopharmacology, 15, 116–126. CrossRef
- American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association. (Text revision).
- Anderson, L., & Walcott, C. M. (2009). Issues in monitoring medication effects in the classroom. Psychology in the Schools, 46(9), 820–826. CrossRef
- Arnold, L. E., Vitiello, B., McDougle, C., Scahill, L., Shah, B., Gonzalez, N. M., et al. (2003). Parent-defined target symptoms respond to risperidone in RUPP autism study: Customer approach to clinical trials. Journal of the American Academy of Child and Adolescent Psychiatry, 42(12), 1443–1450. CrossRef
- Castle, L., Aubert, R. E., Verbrugge, R. R., Khalid, M., & Epstein, R. S. (2007). Trends in medication treatment for ADHD. Journal of Attention Disorders, 10, 335–342. CrossRef
- Coghill, D. (2003). Current issues in child and adolescent psychopharmacology. Part 2: Anxiety and obsessive-compulsive disorders, autism, Tourette’s and schizophrenia. Advances in Psychiatric Treatment, 9, 289–299. CrossRef
- Cohen, J. (1977). Statistical power analysis for the behavioral sciences. Orlando, FL: Academic Press, Inc.
- Dabrowska, A., & Pisula, E. (2010). Parenting stress and coping styles in mothers and fathers of pre-school children with autism and down syndrome. Journal of Intellectual Disabilities Research, 54(3), 266–280. CrossRef
- Ebensen, A. J., Greenberg, J. S., Seltzer, M. M., & Aman, M. G. (2009). A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorder. Journal of Autism and Developmental Disorders, 39, 1339–1349. CrossRef
- Farlow, L. J., & Snell, M. E. (1989). Teacher use of student instructional data to make decisions: Practices in programs for students with moderate to profound disabilities. Journal of the Association for Persons with Severe Handicaps, 14(1), 13–22.
- Foy, J. M., Kelleher, K. J., & Laraque, D. (2010). Enhancing pediatric mental health care: Strategies for preparing a primary care practice. Pediatrics, 125, S87–S108. CrossRef
- Fuchs, L. S., & Fuchs, D. (1986). Effects of systematic formative evaluation: A meta-analysis. Exceptional Children, 53(3), 199–208.
- Galinat, K., Barcalow, K., & Krivda, B. (2005). Caring for children with autism in the school setting. Journal of School Nursing, 21(4), 208–217. CrossRef
- Gerhard, T., Chavez, B., Olfson, M., & Crystal, S. (2009). National patterns in the outpatient pharmacological management of children and adolescents with autism spectrum disorder. Journal of Clinical Psychopharmacology, 29, 307–310. CrossRef
- Green, V., Pituch, K., Itchon, J., Choi, A., O’Reilly, M., & Sigafoos, J. (2006). Internet survey of treatments used by parents of children with autism. Research in Developmental Disabilities, 27(1), 70–84. CrossRef
- Gringas, P., & McNicholas, F. (1999). Developing rational protocols for paediatric psychopharmacological prescribing. Child: Care, Health and Development, 25, 223–233. CrossRef
- Gringras, P. (2000). Practical paediatric psychopharmacological prescribing in autism. Autism, 4, 229–247. CrossRef
- Gureasko-Moore, D. P., DuPaul, G. J., & Power, T. J. (2005). Stimulant treatment for attention-deficit/hyperactivity disorder: Medication monitoring practices of school psychologists. School Psychology Review, 34, 232–245.
- Haile-Mariam, A., Bradley-Johnson, S., & Johnson, C. M. (2002). Pediatricians’ preferences for ADHD information from schools. School Psychology Review, 31, 94–105.
- Hall, H. R., & Graff, J. C. (2011). The relationships among adaptive behaviors of children with autism, family support, parenting stress, and coping. Issues in Comprehensive Pediatric Nursing, 34(1), 4–25. CrossRef
- Hastings, R. P., Kovshoff, H., Brown, T., Ward, N. J., Espinosa, F. D., & Remington, B. (2005). Coping strategies in mothers and fathers of preschool and school-age children with autism. Autism, 9(4), 377–391. CrossRef
- Koegel, R. L., & Koegel, L. K. (2012). The PRT pocket guide. Baltimore, MD: Brookes Publishing Company.
- Koelch, M., Schnoor, K., & Fegert, J. M. (2008). Ethical issues in psychopharmacology of children and adolescents. Current Opinion in Psychiatry, 21, 598–605. CrossRef
- Leskovec, T. J., Rowles, B. M., & Findling, R. L. (2008). Pharmacological treatment options for autism spectrum disorders in children and adolescents. Harvard Review of Psychiatry, 16, 97–112. CrossRef
- Liptak, G. S., Stuart, T., & Auinger, P. (2006). Health care utilization and expenditures for children with autism: Data from U.S. national samples. Journal of Autism and Developmental Disorders, 36, 871–879. CrossRef
- Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. B., Doshi, J., & Polsky, D. E. (2008). Psychotropic medication use among medicaid-enrolled children with autism spectrum disorders. Pediatrics, 121, e441–e448. CrossRef
- Matson, J. L., & Dempsey, T. (2008). Autism spectrum disorders: Pharmacotherapy for challenging behaviors. Journal of Developmental and Physical Disabilities, 20, 175–191. CrossRef
- McCracken, J. T. (2005). Safety issues with drug therapies for autism spectrum disorders. Journal of Clinical Psychiatry, 66, 32–37.
- McDonald, J. H. (2009). Handbook of biological statistics (2nd ed.). Baltimore, MD: Sparky House Publishing.
- Morgan, S., & Taylor, E. (2007). Antipsychotic drugs in children with autism. British Medical Journal, 334, 1069–1070. CrossRef
- Myers, S. M., & Johnson, C. P. (2007). Management of children with autism spectrum disorders. Pediatrics, 120, 1162–1182. CrossRef
- Oswald, P. D., & Sonenklar, N. A. (2007). Medication use among children with autism-spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 17, 348–355. CrossRef
- Pliszka, S. R., Lopez, M., Crismon, M. L., Toprac, M. G., Hughes, C. W., Emslie, G., et al. (2003). A feasibility study of the children’s medication algorithm project (CMAP) algorithm for the treatment of ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 279–287. CrossRef
- Posey, D. J., Sigler, K. A., Erickson, C. A., & McDougle, C. J. (2008). Antipsychotics in the treatment of autism. The Journal of Clinical Investigation, 118(1), 6–14. CrossRef
- Raffin, C. (2001). A multidisciplinary approach to working with autistic children. Educational and Child Psychology, 18(2), 15–29.
- Robb, A. S. (2010). Managing irritability and aggression in autism spectrum disorders in children and adolescents. Developmental Disabilities Research Review, 16(3), 258–264. CrossRef
- Rosenberg, R. E., Mandell, D. S., Farmer, J. E., Law, J. K., Marvin, A. R., & Law, P. A. (2010). Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007–2008. Journal of Autism and Developmental Disorders, 40, 342–351. CrossRef
- Scahill, L., & Martin, A. (2005). Psychopharmacology. In F. R. Volkmar, R. Paul, A. Klin, & D. Cohen (Eds.), Handbook of Autism and pervasive developmental disorders (pp. 1102–1117). Hoboken, NJ: Wiley.
- Shea, S., Turgay, A., Carroll, A., Schulz, M., Orlik, H., Smith, I., et al. (2004). Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics, 114(5), e634–e641. CrossRef
- Steinberg-Epstein, R., Book, T., & Wigal, S. B. (2011). Controversies surrounding pediatric psychopharmacology. Advances in Pediatrics, 58, 153–179. CrossRef
- Swanson, J., Lerner, M., March, J. S., & Gresham, F. (1999). Assessment and intervention for attention-deficit/hyperactivity disorder in the schools. Pediatric Clinics of North America, 46, 993–1009. CrossRef
- Troost, P. W., Lahuis, B., Steenhuis, M., Ketelaars, C. E., Buitelaar, J. K., van Engeland, H., et al. (2005). Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study. Journal of the American Academy of Child and Adolescent Psychiatry, 44(11), 1137–1147. CrossRef
- Vereb, R. L., & DiPerna, J. C. (2004). Teachers’ knowledge of ADHD, treatments for ADHD, and treatment acceptability: An initial investigation. School Psychology Review, 33, 421–428.
- Volkmar, F. R., Lord, C., Bailey, A., Schultz, R. T., & Klin, A. (2004). Autism and pervasive developmental disorders. Journal of Child Psychology and Psychiatry, 45, 135–170. CrossRef
- Volkmar, F. R., Wiesner, L. A., & Westphal, A. (2006). Healthcare issues for children on the autism spectrum. Current Opinion in Psychiatry, 19, 361–366. CrossRef
- Weithorn, C. J., & Ross, R. (1975). Who monitors medication? Journal of Learning Disabilities, 8, 458–461. CrossRef
- Williamson, E. D., & Martin, A. (2010). Psychotropic medications in autism: Practical considerations for parents. Journal of Autism and Developmental Disorders, 42(6), 1249–1255. CrossRef
- Witwer, A., & Lecavalier, L. (2005). Treatment incidence and patterns in children and adolescents with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 15, 671–681. CrossRef
- Wolraich, M. L., Lambert, E. W., Bickman, L., Simmons, T., Doffing, M. A., & Worley, K. A. (2002). Assessing the impact of parent and teacher agreement on diagnosing attention-deficit hyperactivity disorder. Journal of Development and Behavioral Pediatrics, 25, 41–47. CrossRef
- Is Medication Information for Children with Autism Spectrum Disorder Monitored and Coordinated Across Professionals? Findings from a Teacher Survey
School Mental Health
Volume 5, Issue 1 , pp 48-57
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Autism spectrum disorder
- Monitoring medication
- Author Affiliations
- 1. Counseling, Clinical, and School Psychology Department, Koegel Autism Center, Graduate School of Education, University of California, Santa Barbara, CA, 93106-9490, USA
- 2. Pediatrics, Rady Children’s Hospital, University of California, San Diego, CA, USA
- 3. Autism Spectrum Therapies, Los Angeles, CA, USA